Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed1
Other2

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT05896124Phase 2Active Not Recruiting
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Primary Biliary Cholangitis (PBC)
StudydirectorStart date: 2023-08-07
NCT05896137Phase 2Active Not Recruiting
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
Primary Sclerosing Cholangitis
StudydirectorStart date: 2023-08-07
NCT05591079Phase 2Completed
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
Nonalcoholic Steatohepatitis (NASH)
StudydirectorStart date: 2023-02-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05896124Phase 2StudyDirector

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Primary Biliary Cholangitis (PBC)
Active Not Recruiting
NCT05896137Phase 2StudyDirector

CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)

Primary Sclerosing Cholangitis
Active Not Recruiting
NCT05591079Phase 2StudyDirector

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Nonalcoholic Steatohepatitis (NASH)
Completed

All 3 trials loaded